![](/img/cover-not-exists.png)
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
Zeidner, J. F., Foster, M. C., Blackford, A. L., Litzow, M. R., Morris, L. E., Strickland, S. A., Lancet, J. E., Bose, P., Levy, M. Y., Tibes, R., Gojo, I., Gocke, C. D., Rosner, G. L., Little, R. F.,Volume:
100
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2015.125849
Date:
September, 2015
File:
PDF, 1.88 MB
english, 2015